Neurosurgeon to test ReNeuron's stem cell line in stroke victims

12/22/2009 | Bloomberg

A Scottish neurosurgeon will start by early next year a study to test the effectiveness of ReNeuron Group's ReN001 stem cell line in repairing damaged brains of 12 stroke victims. Under the two-year study, male patients will get injections of up to 20 million stem cells derived from the brain of an aborted fetus.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT